New Production Method for Medical-Grade Radioisotopes
By MedImaging International staff writers Posted on 24 Jun 2019 |
A novel technique enables simultaneous production of molybdenum-99 (Mo-99) and other isotopes without the need for highly enriched, weapons-grade uranium.
Developed by BGN Technologies (Beer Sheva; Israel), the technique uses the naturally occurring and stable molybdenum-100 (Mo-100) isotope and a linear electron accelerator to generate Mo-99 and technetium-99m (Tc-99m). The molybdenum target acts both as a bremsstrahlung converter for the incident electron beam, and simultaneously as a Mo-99 producing target via the 100Mo(γ,n)99Mo reaction on bremsstrahlung photons. Even higher rates of molybdenum yield could be achieved by optimizing the target geometry.
The same process can also be used to simultaneously generate other short-lived radioisotopes such as 18F, 15O, 13N and 11C, which can be used as byproducts for use in positron emission tomography (PET) scans. The technology was co-developed by Alexander Tsechanski, PhD, from the department of nuclear engineering at Ben-Gurion University (BGU; Beer Sheva, Israel), and D. V. Fedorchenko, PhD, from the National Science Center Kharkov Institute of Physics and Technology (Ukraine).
“Technetium-99m is a metastable nuclear isomer of technetium-99 that is used in tens of millions of medical diagnostic procedures annually, making it the most commonly used medical radioisotope. The need for uranium and a nuclear reactor to produce this radioisotope is creating a shortage of this important substance,” said Zafrir Levy, senior vice president for business development, exact sciences, and engineering at BGN Technologies. “Tsechanski’s innovation offers a more feasible, cost-effective method, using cheaper electron accelerators for generating Mo99/Tc-99m. We are currently looking for partners for further developing and commercializing this important invention.”
The most important medical isotope, Tc-99m, is obtained from the decay of its parent Mo-99, and is used in more than 80% of all nuclear medicine procedures. Mo-99 is packed into source containment vessels and distributed to hospitals, where nuclear medicine specialists can draw off the Tc-99m as needed for about a week. Because of its unstable nature, Mo-99 does not occur naturally and is traditionally produced using nuclear research reactors powered by enriched uranium in Canada, the Netherlands, Belgium, France, Australia, and South Africa.
Related Links:
Developed by BGN Technologies (Beer Sheva; Israel), the technique uses the naturally occurring and stable molybdenum-100 (Mo-100) isotope and a linear electron accelerator to generate Mo-99 and technetium-99m (Tc-99m). The molybdenum target acts both as a bremsstrahlung converter for the incident electron beam, and simultaneously as a Mo-99 producing target via the 100Mo(γ,n)99Mo reaction on bremsstrahlung photons. Even higher rates of molybdenum yield could be achieved by optimizing the target geometry.
The same process can also be used to simultaneously generate other short-lived radioisotopes such as 18F, 15O, 13N and 11C, which can be used as byproducts for use in positron emission tomography (PET) scans. The technology was co-developed by Alexander Tsechanski, PhD, from the department of nuclear engineering at Ben-Gurion University (BGU; Beer Sheva, Israel), and D. V. Fedorchenko, PhD, from the National Science Center Kharkov Institute of Physics and Technology (Ukraine).
“Technetium-99m is a metastable nuclear isomer of technetium-99 that is used in tens of millions of medical diagnostic procedures annually, making it the most commonly used medical radioisotope. The need for uranium and a nuclear reactor to produce this radioisotope is creating a shortage of this important substance,” said Zafrir Levy, senior vice president for business development, exact sciences, and engineering at BGN Technologies. “Tsechanski’s innovation offers a more feasible, cost-effective method, using cheaper electron accelerators for generating Mo99/Tc-99m. We are currently looking for partners for further developing and commercializing this important invention.”
The most important medical isotope, Tc-99m, is obtained from the decay of its parent Mo-99, and is used in more than 80% of all nuclear medicine procedures. Mo-99 is packed into source containment vessels and distributed to hospitals, where nuclear medicine specialists can draw off the Tc-99m as needed for about a week. Because of its unstable nature, Mo-99 does not occur naturally and is traditionally produced using nuclear research reactors powered by enriched uranium in Canada, the Netherlands, Belgium, France, Australia, and South Africa.
Related Links:
BGN Technologies
Ben-Gurion University
National Science Center Kharkov Institute of Physics and Technology
Ben-Gurion University
National Science Center Kharkov Institute of Physics and Technology
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection